Elisabeth Riedl

3.5k total citations
63 papers, 2.7k citations indexed

About

Elisabeth Riedl is a scholar working on Immunology, Dermatology and Immunology and Allergy. According to data from OpenAlex, Elisabeth Riedl has authored 63 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 25 papers in Dermatology and 15 papers in Immunology and Allergy. Recurrent topics in Elisabeth Riedl's work include Psoriasis: Treatment and Pathogenesis (20 papers), Dermatology and Skin Diseases (18 papers) and Immunotherapy and Immune Responses (15 papers). Elisabeth Riedl is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (20 papers), Dermatology and Skin Diseases (18 papers) and Immunotherapy and Immune Responses (15 papers). Elisabeth Riedl collaborates with scholars based in Austria, United States and Germany. Elisabeth Riedl's co-authors include Walter Knapp, Otto Majdic, Herbert Strobl, Winfried F. Pickl, C Bello-Fernández, Clemens Scheinecker, Johannes Stöckl, Klemens Rappersberger, Harald Kittler and Philipp Kohl and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Blood.

In The Last Decade

Elisabeth Riedl

62 papers receiving 2.6k citations

Peers

Countries citing papers authored by Elisabeth Riedl

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Riedl more than expected).

Fields of papers citing papers by Elisabeth Riedl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Riedl. The network helps show where Elisabeth Riedl may publish in the future.

Co-authorship network of co-authors of Elisabeth Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Riedl. A scholar is included among the top collaborators of Elisabeth Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Riedl. Elisabeth Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO) 2024 ·Acta Dermato Venereologica ·April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, (unknown), (unknown), Bruce W. Konicek, Zbigniew Kadziola, Mercedes Núñez, Alan Brnabic, Christopher F. Schuster	2
2	Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO 2024 ·Dermatology and Therapy ·Elisabeth Riedl, Andreas Pinter, (unknown), Antonio Costanzo, Alan Brnabic, Bruce W. Konicek, Robert Tracy McKenzie, Αναστασία Λαμπροπούλου, (unknown), (unknown), Christopher Schuster	3
3	42592 Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients with Moderate-to- Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics in the Psoriasis Study of Health Outcomes (PSoHO) 2023 ·Journal of the American Academy of Dermatology ·Alexander Egeberg, Andreas Pinter, Ronald Vender, (unknown), Alan Brnabic, Christopher F. Schuster, (unknown), Catherine Reed, Elisabeth Riedl, L. Puig	1
4	Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks 2023 ·Journal of the European Academy of Dermatology and Venereology ·Adam Reich, Andreas Pinter, Julia‐Tatjana Maul, Ronald Vender, Tiago Torres, Alan Brnabic, (unknown), Catherine Reed, Christopher Schuster, Elisabeth Riedl	6
5	Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO) 2023 ·Dermatology and Therapy ·Andreas Pinter, Antonio Costanzo, Sanjay Khattri, Stephen D. Smith, J.M. Carrascosa, Yayoi Tada, Elisabeth Riedl, Adam Reich, Alan Brnabic, (unknown), (unknown), Ilya Lipkovich, Zbigniew Kadziola, C. Paul, Christopher Schuster	8
6	Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis 2023 ·Dermatology and Therapy ·C. Paul, C.E.M. Griffiths, Antonio Costanzo, Pedro Herranz, Susanne Grond, (unknown), (unknown), Elisabeth Riedl, Matthias Augustin	8
7	Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO) 2023 ·Frontiers in Medicine ·Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, Ronald Vender, (unknown), (unknown), (unknown), Gaia Gallo, Christopher Schuster, Patrick M. Brunner	20
8	Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial 2022 ·Dermatology Practical & Conceptual ·Kristian Reich, Lars Erik Kristensen, Saxon D. Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert Tracy McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham	18
9	Application of an interactive diagnosis ranking algorithm in a simulated vignette-based environment for general dermatology 2022 ·Dermatology Practical & Conceptual ·(unknown), Elisabeth Riedl, Harald Kittler, Philipp Tschandl	1
10	Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen 2016 ·Wiener klinische Wochenschrift ·Ursula Wiedermann, Harald H. Sitte, Heinz Burgmann, Alexander Eser, (unknown), Heidemarie Holzmann, Maria Kitchen, Marcus Köller, Herwig Kollaritsch, Michael Kundi, Hans Lassmann, I Mutz, Winfried F. Pickl, Elisabeth Riedl, Maria Sibilia, Florian Thalhammer, (unknown), Werner Zenz, Karl Zwiauer	28
11	Clinical improvement in psoriasis with specific targeting of interleukin-23 2015 ·Nature ·Tamara Kopp, Elisabeth Riedl, Christine Bangert, Edward P. Bowman, Elli K. Greisenegger, Ann D. Horowitz, Harald Kittler, Wendy M. Blumenschein, Terrill K. McClanahan, Thomas Marbury, Claus Zachariae, Danlin Xu, Xiaoli Hou, Anish Mehta, Anthe S. Zandvliet, Diana Montgomery, (unknown), Sauzanne Khalilieh	165
12	An itchy rash in a young Caucasian woman 2012 ·Dermatology Practical & Conceptual ·Constanze Jonak, Elisabeth Riedl	4
13	Fixed drug eruption caused by mefenamic acid: a case series and diagnostic algorithms 2011 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alessandra Handisurya, (unknown), Elisabeth Riedl, Christina M. Reinisch, Georg Stingl, Stefan Wöhrl	15
14	A Novel Glycine Mutation in the Col7a1 Gene Leading to Dominant Dystrophic Epidermolysis Bullosa with Intra‐Familial Phenotypical Heterogeneity 2009 ·Pediatric Dermatology ·Elisabeth Riedl, Alfred Klausegger, Johann Bauer, Dagmar Foedinger, Harald Kittler	3
15	Identification and Characterization of Endogenous Langerin Ligands in Murine Extracellular Matrix 2006 ·Journal of Investigative Dermatology ·Yayoi Tada, Elisabeth Riedl, Mark S. Lowenthal, Lance A. Liotta, (unknown), Erika C. Crouch, Mark C. Udey	15
16	Identification and Characterization of an Alternatively Spliced Isoform of Mouse Langerin/CD207 2004 ·Journal of Investigative Dermatology ·Elisabeth Riedl, Yayoi Tada, Mark C. Udey	13
17	Functional Involvement of E-Cadherin in TGF-β1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells 2000 ·The Journal of Immunology ·Elisabeth Riedl, Johannes Stöckl, Otto Majdic, Clemens Scheinecker, Klemens Rappersberger, Walter Knapp, Herbert Strobl	53
18	Identification of CD68+lin− Peripheral Blood Cells with Dendritic Precursor Characteristics 1998 ·The Journal of Immunology ·Herbert Strobl, Clemens Scheinecker, Elisabeth Riedl, (unknown), C Bello-Fernández, Winfried F. Pickl, Otto Majdic, Walter Knapp	113
19	Quantification of motor deficit in Parkinson's disease with a motor performance test series 1992 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Michaela M. Pinter, R. J. Helscher, Christian Našel, Elisabeth Riedl, (unknown)	24
20	�tiologie und Konsequenz der postoperativen Wundinfektion 1991 ·Langenbeck s Archives of Surgery ·Michael A. Rogy, (unknown), Elisabeth Riedl, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact